Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm, BCAN Partner on Bladder Cancer Genomic Profiling

NEW YORK (GenomeWeb) – The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership aimed at improving the genomic profiling of bladder cancer. 

The partners will collaborate on a large-scale genomic study that will also include participation by medical centers. The goal is to facilitate the development of new drug treatments for bladder cancer based on a better understanding of the genomic underpinnings of the disease. 

Eight institutions are expected to work with BCAN on the study: Dana-Farber Cancer Institute; the Johns Hopkins University; MD Anderson Cancer Center; Memorial Sloan-Kettering Cancer Center; the University of Chicago; the University of Michigan; and the University of North Carolina, Chapel Hill. The Hoosier Cancer Research Network (HCRN) will act as the coordinating center. 

The centers will initially enroll 200 metastatic urothelial cancer patients, who will be genomically profiled by Paradigm with next-generation sequencing. Their physicians will receive the results as well as information about potential clinical trials related to the patients' findings. 

Results from the study will be housed at HCRN. 

The study is the first project of the Bladder Cancer Genomics Consortium (BCGC), a collaboration between BCAN and major medical centers, BCAN and Paradigm said, adding BCGC partners will have access to the data from the study for collaborative translational research and to facilitate the development of new treatments. 

BCAN is investing an initial $1.6 million to support study management, support services, and sequencing reporting. 

"We hope this new program will be a game-changer in the field of bladder cancer research, bringing new treatment options to those who need it now, and fostering collaborative translational research that will ultimately save lives," BCGC Genomics Advisory Board Chair Matthew Milowsky, who also is the principal investigator on the study, said in a statement.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.